Shannon M. Hansen - 15 Aug 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & Chief Legal Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for Shannon M. Hansen
Issuer symbol
TNDM
Transactions as of
15 Aug 2024
Net transactions value
-$30,805
Form type
4
Filing time
19 Aug 2024, 20:31:52 UTC
Previous filing
28 May 2024
Next filing
19 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +531 +6.3% $0.000000 8,944 15 Aug 2024 Direct
transaction TNDM Common Stock Tax liability $8,326 -190 -2.1% $43.82 8,754 15 Aug 2024 Direct F1
transaction TNDM Common Stock Options Exercise $0 +1,437 +16% $0.000000 10,191 15 Aug 2024 Direct
transaction TNDM Common Stock Tax liability $22,480 -513 -5% $43.82 9,678 15 Aug 2024 Direct F1
holding TNDM Common Stock 1,935 15 Aug 2024 Shannon M. Hansen Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -531 -14% $0.000000 3,184 15 Aug 2024 Common Stock 531 Direct F3, F4, F5
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,437 -12% $0.000000 10,060 15 Aug 2024 Common Stock 1,437 Direct F6, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee.
F3 Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F4 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F5 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F6 Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F7 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F8 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.